Comparative Superiority of in vitro Activity of DW-224a Supported by the Downward MIC Distribution in Ciprofloxacin-resistant Staphylococcus aureus
![]() |
Yoon, Eun-Jeong
(College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lee, Chun-Yeong (Department of Life Science, University of Seou) Lee, Jong-Seo (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Choe, Eung-Chil (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Shim, Mi-Ja (Department of Life Science, University of Seoul) |
1 | J.M. Entenza, Y.A. Que, J. Vouillamoz, M.P. Glauser and P. Moreillon, Efficacies of moxifloxacin, ciprofloxacin and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob. Agents Chemother. 45, 3076-3083 (2001). DOI ScienceOn |
2 | J. Han, J.C. Kim, M.K. Chung, B. Kim and D.R. Choi, Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs. Biol. Pharm. Bull. 26, 832-839 (2003) DOI ScienceOn |
3 | D.C. Hooper, Mechanisms of action and resistance of older and newer quinolones. Clin. Infect. Dis. 31, S24-S28 (2000). DOI ScienceOn |
4 | F.J. Schmitz, M.E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Luckefahr, A. Fluit, J. Verihoef, U. Hadding H.P. Heinz and K. Kohrer, Characterization of grlA, grlB, gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252 (1998) |
5 | H.J. Yun, Y.H. Min, Y.W. Jo, M.J. Shim and E.C. Choi, Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV. Int. J. Antimicrob. Agents 25:334-337 (2005) DOI ScienceOn |
6 | M. Tanaka, T. Wang, Y. Onodera, Y. Uchida and K. Sato, Mechanisms of quinolone resistance in Staphylococcus aureus J. Infect. Chemother. 6, 131-139 (2000). DOI ScienceOn |
7 | National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Fifth Edition. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA. 11. (2000). |
8 | R.N. Jones, D.J. Biedenbach, P.G. Ambrose and M.A. Wikler, Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. Diagn. Microbiol. Infect. Dis. 62, 110-112 (2008). DOI ScienceOn |
9 | H.S. Park, H.J. Kim, M.J. Seol, D.R. Choi, E.C. Choi and J.H. Kwak, In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob. Agents Chemother. 50, 2261 -2264 (2006). DOI ScienceOn |
10 | A.R. Kwon, Y.H. Min, J.M. Ryu, D.R. Choi, M.J. Shim and E.C. Choi, In vitro and in vivo activities of DW-224a a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58, 684 -688 (2006). DOI ScienceOn |
![]() |